Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. GSK plc
  6. News
  7. Summary
    GSK   GB00BN7SWP63

GSK PLC

(GSK)
  Report
Delayed London Stock Exchange  -  11:35:03 2023-01-26 am EST
1405.20 GBX   +0.11%
10:46aUK earnings, trading statements calendar - next 7 days
AN
01/25UK earnings, trading statements calendar - next 7 days
AN
01/25GSK : Barclays reiterates its Neutral rating
MD
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

GSK, Pfizer, Sanofi Breathe Sigh Of Relief After US Court Tosses Lawsuits On Zantac Cancer Link

12/07/2022 | 04:38am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
GSK PLC 0.11% 1405.2 Delayed Quote.-2.37%
JOHNSON & JOHNSON -0.37% 168.89 Delayed Quote.-4.72%
PFIZER, INC. -0.92% 44.25 Delayed Quote.-12.74%
SANOFI -0.21% 89.72 Real-time Quote.0.08%
All news about GSK PLC
10:46aUK earnings, trading statements calendar - next 7 days
AN
01/25UK earnings, trading statements calendar - next 7 days
AN
01/25GSK : Barclays reiterates its Neutral rating
MD
01/24Pharma Stocks Weigh Down European Equities in Tuesday Trading
MT
01/24Europe's revenue growth expected to slow to a crawl in Q4
RE
01/24UK's FTSE 100 slips ahead of business activity data
RE
01/23Bayer Chairman Faces Criticism From Investor for Lack of Initiative, WirtschaftsWoche R..
DJ
01/19GSK : JP Morgan reaffirms its Sell rating
MD
01/18Factbox-Moderna data puts the spotlight on RSV vaccines under development
RE
01/18FTSE 100 Closes Down 0.3% as UK Inflation Puts Pressure on Pound
DJ
More news
Analyst Recommendations on GSK PLC
More recommendations
Financials
Sales 2022 29 111 M 35 987 M 35 987 M
Net income 2022 6 197 M 7 661 M 7 661 M
Net Debt 2022 14 605 M 18 055 M 18 055 M
P/E ratio 2022 8,90x
Yield 2022 4,34%
Capitalization 57 065 M 70 545 M 70 545 M
EV / Sales 2022 2,46x
EV / Sales 2023 2,41x
Nbr of Employees 90 096
Free-Float 93,7%
Chart GSK PLC
Duration : Period :
GSK plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GSK PLC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 22
Last Close Price 1 405,20 GBX
Average target price 1 694,98 GBX
Spread / Average Target 20,6%
EPS Revisions
Managers and Directors
Emma N. Walmsley Chief Executive Officer & Executive Director
Iain James Mackay Chief Financial Officer & Executive Director
Jonathan Richard Symonds Non-Executive Chairman
Jon Ellis VP & Head-Technology Business Development
Tony Wood Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
GSK PLC-2.37%70 415
JOHNSON & JOHNSON-4.72%443 181
ELI LILLY AND COMPANY-5.32%332 306
NOVO NORDISK A/S1.07%313 303
ROCHE HOLDING AG1.07%281 267
MERCK & CO., INC.-2.13%275 319